XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Equity-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of details regarding stock option activity
The following table summarizes stock option activity for the six months ended June 30, 2020:
 20192007Lumara HealthInducement 
 PlanPlan2013 PlanGrantsTotal
Outstanding at December 31, 2019472,412  2,585,466  131,775  696,164  3,885,817  
Granted420,912  —  —  1,000,000  1,420,912  
Exercised—  —  —  —  —  
Expired or terminated(95,650) (415,876) (21,475) (99,598) (632,599) 
Outstanding at June 30, 2020797,674  2,169,590  110,300  1,596,566  4,674,130  
Summary of details regarding restricted stock activity
The following table summarizes RSU activity for the six months ended June 30, 2020:
 20192007Lumara HealthInducement 
 PlanPlan2013 PlanGrantsTotal
Outstanding at December 31, 2019128,742  1,407,305  2,167  41,223  1,579,437  
Granted736,831  —  —  —  736,831  
Vested(67,526) (448,217) (899) (5,530) (522,172) 
Expired or terminated(148,746) (500,987) (534) (3,001) (653,268) 
Outstanding at June 30, 2020649,301  458,101  734  32,692  1,140,828  
Schedule of equity-based compensation expense
Equity-based compensation expense for the three and six months ended June 30, 2020 and 2019 consisted of the following (in thousands):
 Three Months Ended June 30,Six Months Ended June 30,
 2020201920202019
Cost of product sales$104  $198  $307  $401  
Research and development(48) 680  23  1,360  
Selling, general and administrative2,037  3,656  5,549  6,981  
Total equity-based compensation expense2,093  4,534  5,879  8,742  
Income tax effect—  —  —  —  
After-tax effect of equity-based compensation expense$2,093  $4,534  $5,879  $8,742